Detalhe da pesquisa
1.
Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility.
Drug Dev Ind Pharm
; 42(2): 190-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-25996463
2.
Development and validation of an RP-HPLC method for CB13 evaluation in several PLGA nanoparticle systems.
ScientificWorldJournal
; 2012: 737526, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22792051
3.
Insulin-loaded PLGA microparticles: flow focusing versus double emulsion/solvent evaporation.
J Microencapsul
; 28(5): 430-41, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21736527
4.
In vivo biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles.
Expert Opin Drug Deliv
; 16(12): 1413-1427, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31694417
5.
Development and in vitro evaluation of a controlled release formulation to produce wide dose interval morphine tablets.
Eur J Pharm Biopharm
; 70(2): 544-9, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18588973
6.
Synthesis of lidocaine-loaded PLGA microparticles by flow focusing. Effects on drug loading and release properties.
Int J Pharm
; 358(1-2): 27-35, 2008 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-18372128
7.
Role of Nanotechnology for Enzyme Replacement Therapy in Lysosomal Diseases. A Focus on Gaucher's Disease.
Curr Med Chem
; 23(9): 929-52, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26860997
8.
In vitro and in vivo evaluation of Δ9-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy.
Int J Pharm
; 487(1-2): 205-12, 2015 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25899283
9.
Development of enteric-coated timed-release matrix tablets for colon targeting.
J Drug Target
; 12(9-10): 607-12, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15621686
10.
A rapid HPLC method for the quantification of tyrothricin, menthol, and benzocaine in pharmaceutical formulations.
J Pharm Sci
; 83(8): 1147-9, 1994 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-7983600
11.
Preclinical study of an oral controlled release naltrexone complex in mice.
J Pharm Pharmacol
; 52(6): 659-63, 2000 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-10875542
12.
Effectiveness of repeated administration of a new oral naltrexone controlled-release system on morphine analgesia.
J Pharm Pharmacol
; 53(9): 1201-5, 2001 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-11578102
13.
Eudragit RS-PM and Ethocel 100 Premium: influence over the behavior of didanosine inert matrix system.
Farmaco
; 57(8): 649-56, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12361232
14.
Functional PLGA NPs for oral drug delivery: recent strategies and developments.
Mini Rev Med Chem
; 13(1): 58-69, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22974367
15.
Drug targeting to cancer by nanoparticles surface functionalized with special biomolecules.
Curr Med Chem
; 19(19): 3188-95, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22612702
16.
Possibilities of poly(D,L-lactide-co-glycolide) in the formulation of nanomedicines against cancer.
Curr Drug Targets
; 12(8): 1096-111, 2011 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21443478
17.
Nanostructures for drug delivery to the brain.
Curr Med Chem
; 18(34): 5303-21, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22087827
18.
Validation study of the conductometrical analysis. Application to the drug release studies from controlled release systems.
J Pharm Biomed Anal
; 18(1-2): 281-5, 1998 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-9863971
19.
Protein-loaded PLGA microparticles engineered by flow focusing: physicochemical characterization and protein detection by reversed-phase HPLC.
Int J Pharm
; 380(1-2): 147-54, 2009 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19635540
20.
Elaboration and "in vitro" characterization of 5-ASA beads.
Drug Dev Ind Pharm
; 31(2): 231-9, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15773290